Doo Sun Sim

Title: Innovations by Doo Sun Sim in Drug-Eluting Stents

Introduction

Doo Sun Sim is a notable inventor based in Gwangju, South Korea. He has made significant contributions to the field of medical devices, particularly in the development of drug-eluting stents. With a total of three patents to his name, his work focuses on enhancing the efficacy and safety of stents used in coronary interventions.

Latest Patents

One of his latest patents is for a non-polymeric tacrolimus drug-eluting stent and the manufacturing method associated with it. This innovative method allows for a strong and stable binding of tacrolimus drug onto the stent without the need for additional surface-binding functional groups. The resulting stent exhibits a greater total drug elution amount and improved delayed drug-elution properties. Another significant patent involves a method for manufacturing a polymer-free everolimus-eluting coronary stent using an electrospinning technique. This approach enables precise control over the drug content and ensures a uniform layer without the use of polymers that could lead to late thrombosis.

Career Highlights

Doo Sun Sim is affiliated with Chonnam National University, where he continues to advance research in medical technology. His work has garnered attention for its potential to improve patient outcomes in cardiovascular treatments.

Collaborations

He collaborates with esteemed colleagues such as Dae Sung Park and In-Ho Bae, contributing to a dynamic research environment focused on innovative medical solutions.

Conclusion

Doo Sun Sim's contributions to the field of drug-eluting stents exemplify the impact of innovation in medical technology. His patents reflect a commitment to improving the effectiveness and safety of cardiovascular interventions.